Follow
Andreas von Deimling
Andreas von Deimling
Neuropathology, University Heidelberg / CCU Neuropathology, German Cancer Center
Verified email at med.uni-heidelberg.de
Title
Cited by
Cited by
Year
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131, 803-820, 2016
158672016
The 2021 WHO classification of tumors of the central nervous system: a summary
DN Louis, A Perry, P Wesseling, DJ Brat, IA Cree, D Figarella-Branger, ...
Neuro-oncology 23 (8), 1231-1251, 2021
57842021
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
43362018
Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma
J Schwartzentruber, A Korshunov, XY Liu, DTW Jones, E Pfaff, K Jacob, ...
Nature 482 (7384), 226-231, 2012
26162012
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
25372018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
23942018
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
22112018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
21322018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
19952018
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma
D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ...
Cancer cell 22 (4), 425-437, 2012
19422012
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
18402011
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
15532018
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
C Hartmann, J Meyer, J Balss, D Capper, W Mueller, A Christians, ...
Acta neuropathologica 118, 469-474, 2009
12892009
Analysis of the IDH1 codon 132 mutation in brain tumors
J Balss, J Meyer, W Mueller, A Korshunov, C Hartmann, A von Deimling
Acta neuropathologica 116, 597-602, 2008
12832008
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification
CL Nutt, DR Mani, RA Betensky, P Tamayo, JG Cairncross, C Ladd, ...
Cancer research 63 (7), 1602-1607, 2003
11622003
Long-term survival with glioblastoma multiforme
D Krex, B Klink, C Hartmann, A Von Deimling, T Pietsch, M Simon, ...
Brain 130 (10), 2596-2606, 2007
11002007
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra …
G Schindler, D Capper, J Meyer, W Janzarik, H Omran, C Herold-Mende, ...
Acta neuropathologica 121, 397-405, 2011
10852011
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
M Weller, M van den Bent, M Preusser, E Le Rhun, JC Tonn, G Minniti, ...
Nature reviews Clinical oncology 18 (3), 170-186, 2021
10812021
Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups
KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ...
Cancer cell 27 (5), 728-743, 2015
10792015
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
W Wick, C Hartmann, C Engel, M Stoffels, J Felsberg, F Stockhammer, ...
Journal of clinical oncology 27 (35), 5874, 2009
9632009
The system can't perform the operation now. Try again later.
Articles 1–20